SCHEMBL5146332

SCHEMBL5146332

NC(=O)CC(=S)Nc1ccc(F)cc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
IDO1 P14902 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
POLB P06746 1/20 0.51
GAA P10253 2/20 0.49
MAPT P10636 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA4 P22748 2/20 0.47
CA9 Q16790 2/20 0.47
LMNA P02545 2/20 0.46
ALOX12 P18054 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TGM2 P21980 1/20 0.46
CA12 O43570 1/20 0.45
CA7 P43166 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL410774 0.81 ALDH1A1 (0.64) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL3069525 0.81 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL9412167 0.79 IDO1 (0.57) ALDH1A1IDO1MEN1KMT2APOLB
SCHEMBL5169940 0.77 IDO1 (0.56) ALDH1A1IDO1MEN1KMT2AMAPT
SCHEMBL8720523 0.77 IDO1 (0.56) ALDH1A1IDO1MEN1KMT2APOLB
SCHEMBL145719 0.76 IDO1 (0.63) ALDH1A1IDO1MEN1KMT2APOLB
SCHEMBL1091812 0.76 ALDH1A1 (1.00) ALDH1A1IDO1MEN1KMT2AGAA
SCHEMBL12947940 0.75 MAPT (0.56) ALDH1A1IDO1MEN1KMT2APOLB
SCHEMBL2329827 0.74 ALDH1A1 (0.60) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL11634169 0.74 ALDH1A1 (0.66) ALDH1A1IDO1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7288556-B2 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2007-10-30 US disclosed
US-7022702-B2 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2006-04-04 US disclosed
US-20060009500-A1 Antiproliferative 1,2,3-thiadiazole compounds QLT INC. (CA) 2006-01-12 US disclosed
US-20030096848-A1 Antiproliferative 1,2,3-thiadiazole compounds DERMIRA (CANADA), INC. 2003-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096848-A1 Antiproliferative 1,2,3-thiadiazole compounds CCNA1, CCND1, CCND3 ALDH1A1 1001/4885IDO1 241/4885MEN1 2585/4885
US-20060009500-A1 Antiproliferative 1,2,3-thiadiazole compounds CCNA1, CCND3, ACIN1 ALDH1A1 715/4885IDO1 897/4885MEN1 1548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.